Revenue - Sinovac Biotech Ltd (NASDAQ:SVA) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 6.47 USD

Updated:

Sinovac Biotech Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Sinovac Biotech Ltd
Revenue Peer Comparison

6160

1801

603392

S

002252

300122

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Sinovac Biotech Ltd NASDAQ:SVA	Revenue $1.5B	CAGR 3-Years 82%	CAGR 5-Years 54%	CAGR 10-Years N/A
	Beigene Ltd HKEX:6160	Revenue ¥9.6B	CAGR 3-Years 48%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Innovent Biologics Inc HKEX:1801	Revenue ¥6.2B	CAGR 3-Years 17%	CAGR 5-Years 266%	CAGR 10-Years N/A
	Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Revenue ¥5.5B	CAGR 3-Years 33%	CAGR 5-Years 41%	CAGR 10-Years N/A
S	Shanghai RAAS Blood Products Co Ltd SZSE:002252	Revenue ¥7.6B	CAGR 3-Years 41%	CAGR 5-Years 32%	CAGR 10-Years 27%
	Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Revenue ¥49.7B	CAGR 3-Years 53%	CAGR 5-Years 65%	CAGR 10-Years 50%

Sinovac Biotech Ltd
Revenue Breakdown

Total Revenue: 1.5B USD

100%

Prc: 1.1B USD

74.8%

Outside Mainland China: 376m USD

25.2%

See Also

Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's Revenue amounts to 1.5B USD.

Over the last year, the Revenue growth was -92%. The average annual Revenue growth rates for Sinovac Biotech Ltd have been 82% over the past three years , 54% over the past five years .

Join more than 133,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.